cigan posed a pertinent question posed by piney on IV. Why register securities earmarked for stock incentive plan now?
1) they don't intend to use the new stock for incentive pay, instead just raise cash
2) they have or will soon achieve milestones for which incentive stock may be awarded
I think most believe number 1. I think that would get them in big trouble.
I vote number 2. So if I'm right what are the possibilities?
phase 3 initiated
The incentives are probably enumerated in the 2011 incentive plan cited in the S-8 and referenced in the 10-Q
In any case I think this means an important milestone will be accomplished before the end of the year.
Marburg clinical trial is complete.
That is the milestone.
That is probably also the milestone that Chris is more excited about than DMD.
The antivirals are safe and effective.
There should be a PR very soon on the antivirals that will refocus attention on our other pipelines.
While I downplayed the bio security pipeline recently, what is important is validation of the platform wrt antivirals. Selling a marburg treatment to the government isn't going to create the kind of value this company needs to regain its market cap. But if the marburg drug works there's more reason to believe the flu drug will too. Flu is potentially a 10 billion annual market worldwide.